# eribulin mesylate

NDC: 68083-592
Generic name: eribulin mesylate
Labeler / Manufacturer: Gland Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20240405

FDA application: ANDA218047

## Active ingredients

- ERIBULIN MESYLATE: .5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68083-592"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68083-592
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f57835e2-4c53-4e93-b54b-7d7a5000ae3d